Return to Listing

1 result(s) for Halaven

PI Name Protocol # Title
Kathleen Kemmer STUDY00015176 A Randomized Open-Label Phase 3 Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician's Choice for Metastatic Triple Negative Breast Cancer (mTNBC)

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080